160 related articles for article (PubMed ID: 19851705)
1. Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study.
Schirman S; Kronenberg S; Apter A; Brent D; Melhem N; Pick N; Carmel M; Frisch A; Weizman A; Gothelf D
J Neural Transm (Vienna); 2010 Jan; 117(1):139-45. PubMed ID: 19851705
[TBL] [Abstract][Full Text] [Related]
2. Citalopram in children and adolescents with depression or anxiety.
Baumgartner JL; Emslie GJ; Crismon ML
Ann Pharmacother; 2002 Nov; 36(11):1692-7. PubMed ID: 12398561
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
[TBL] [Abstract][Full Text] [Related]
4. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.
Kronenberg S; Apter A; Brent D; Schirman S; Melhem N; Pick N; Gothelf D; Carmel M; Frisch A; Weizman A
J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):741-50. PubMed ID: 18315446
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of citalopram in adolescents with depression.
Bostic JQ; Prince J; Brown K; Place S
J Child Adolesc Psychopharmacol; 2001; 11(2):159-66. PubMed ID: 11436955
[TBL] [Abstract][Full Text] [Related]
6. The influence of educational information on depressed outpatients treated with escitalopram: a semi-naturalistic study.
Leinonen E; Niemi H
Nord J Psychiatry; 2007; 61(2):109-14. PubMed ID: 17454725
[TBL] [Abstract][Full Text] [Related]
7. Treatment of comorbid anxiety and depression with escitalopram: results of a post-marketing surveillance study.
Laux G; Friede M; Müller WE
Pharmacopsychiatry; 2013 Jan; 46(1):16-22. PubMed ID: 22648305
[TBL] [Abstract][Full Text] [Related]
8. An open-label trial of nefazodone in high comorbidity panic disorder.
DeMartinis NA; Schweizer E; Rickels K
J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
[TBL] [Abstract][Full Text] [Related]
9. Citalopram in the treatment of dysthymic disorder.
Hellerstein DJ; Batchelder S; Miozzo R; Kreditor D; Hyler S; Gangure D; Clark J
Int Clin Psychopharmacol; 2004 May; 19(3):143-8. PubMed ID: 15107656
[TBL] [Abstract][Full Text] [Related]
10. Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer.
Gothelf D; Rubinstein M; Shemesh E; Miller O; Farbstein I; Klein A; Weizman A; Apter A; Yaniv I
J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1258-62. PubMed ID: 16292117
[TBL] [Abstract][Full Text] [Related]
11. Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany.
Möller HJ; Langer S; Schmauss M
Pharmacopsychiatry; 2007 Mar; 40(2):53-7. PubMed ID: 17447173
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram: efficacy and tolerability in the treatment of depression.
Baldwin DS
Hosp Med; 2002 Nov; 63(11):668-71. PubMed ID: 12474611
[TBL] [Abstract][Full Text] [Related]
13. Brief report: citalopram in child and adolescent depression with anxiety.
Schaller JL; Behar D
MedGenMed; 2001 Oct; 3(5):1. PubMed ID: 11698908
[No Abstract] [Full Text] [Related]
14. Anxious depression and response to treatment.
Nelson JC
Am J Psychiatry; 2008 Mar; 165(3):297-9. PubMed ID: 18316424
[No Abstract] [Full Text] [Related]
15. Escitalopram and suicidality in adult depression and anxiety.
Pedersen AG
Int Clin Psychopharmacol; 2005 May; 20(3):139-43. PubMed ID: 15812263
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of citalopram in hospitalized adolescents with major depression: a preliminary, 8-week, fixed-dose, open-label, prospective study.
Shoval G; Nahshoni E; Gothelf D; Manor I; Golobchik P; Zemishlany Z; Weizman A; Zalsman G
Clin Neuropharmacol; 2011; 34(5):182-5. PubMed ID: 21926484
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.
von Knorring AL; Olsson GI; Thomsen PH; Lemming OM; Hultén A
J Clin Psychopharmacol; 2006 Jun; 26(3):311-5. PubMed ID: 16702897
[TBL] [Abstract][Full Text] [Related]
18. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study.
Campo JV; Perel J; Lucas A; Bridge J; Ehmann M; Kalas C; Monk K; Axelson D; Birmaher B; Ryan N; Di Lorenzo C; Brent DA
J Am Acad Child Adolesc Psychiatry; 2004 Oct; 43(10):1234-42. PubMed ID: 15381890
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
Olié JP; Tonnoir B; Ménard F; Galinowski A
Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922
[TBL] [Abstract][Full Text] [Related]
20. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia.
Karlsson I; Godderis J; Augusto De Mendonça Lima C; Nygaard H; Simányi M; Taal M; Eglin M
Int J Geriatr Psychiatry; 2000 Apr; 15(4):295-305. PubMed ID: 10767728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
